<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04270799</url>
  </required_header>
  <id_info>
    <org_study_id>CCR5215</org_study_id>
    <nct_id>NCT04270799</nct_id>
  </id_info>
  <brief_title>Lung Nodule Imaging Biobank for Radiomics and AI Research</brief_title>
  <acronym>LIBRA</acronym>
  <official_title>Lung Nodule Imaging Biobank for Radiomics and AI Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Marsden NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RM Partners West London Cancer Alliance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lewisham and Greenwich NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Epsom and St Helier University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute of Cancer Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UCLH Biomedical Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Marsden NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will collect retrospective CT scan images and clinical data from participants with&#xD;
      incidental lung nodules seen in hospitals across London. The investigators will research&#xD;
      whether machine learning can be used to predict which participants will develop lung cancer,&#xD;
      to improve early diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development of an imaging biobank</measure>
    <time_frame>1 year</time_frame>
    <description>The primary endpoint will be met if we are able to store baseline CT scans and the minimum clinical data set for 1000 patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discovery of a CT-thorax based radiomics profile to predict cancer risk.</measure>
    <time_frame>1 year</time_frame>
    <description>We aim to identify distinct clusters of radiomics variables to generate a radiomics predictive vector (RPV), which can be used to stratify patients according to malignancy risk. This vector will be used in multivariate analysis and compared to existing risk models.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Pulmonary Nodule, Multiple</condition>
  <condition>Pulmonary Nodule, Solitary</condition>
  <condition>Lung Neoplasms</condition>
  <arm_group>
    <arm_group_label>Lung Nodules</arm_group_label>
    <description>A cohort of 1000 patients with incidental lung nodules will be identified using clinical records at participating NHS sites.&#xD;
Link-anonymised CT scan images and data will be stored using a central database for radiomics and artificial intelligence research, to predict the risk of malignancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Machine Learning Classification</intervention_name>
    <description>Patient's scans will be used as input into in-house software to extract multiple radiomics features. These features will be used to develop a risk-signature which can predict malignancy risk. Patient scans will also be used as input into deep learning/convolutional neural network models to perform automated imaging classification.</description>
    <arm_group_label>Lung Nodules</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      CT scan images.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with previously identified lung nodules.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18&#xD;
&#xD;
          -  Baseline CT thorax imaging reported as having pulmonary nodule(s) between 5 and 30mm&#xD;
             in the last 10 years.&#xD;
&#xD;
          -  Ground truth known (either scan data showing stability for 2 years (based on diameter)&#xD;
             or one year (based on volumetry), complete resolution, or biopsy-proven malignancy.&#xD;
&#xD;
          -  Slice thickness &lt; 2.5mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ Absence of at least one technically adequate CT thorax imaging series (defined by&#xD;
             visual inspection of presence of imaging data of the thorax in the DICOM record).&#xD;
&#xD;
               -  Slice thickness &gt; 2.5mm.&#xD;
&#xD;
               -  Imaging &gt; 10 years old.&#xD;
&#xD;
               -  Ground truth unknown.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Lee, MBBS PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The Royal Marsden Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Lee, MBBS PhD</last_name>
    <phone>020 7352 8171</phone>
    <email>richard.lee@rmh.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Marsden - Surrey</name>
      <address>
        <city>Sutton</city>
        <state>England</state>
        <zip>SM2 5PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Hunter</last_name>
      <email>benjamin.hunter@rmh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Richard Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lewisham and Greenwich NHS Trust</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>SE6 4JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Shafick Gareeboo</last_name>
      <email>shafick.gareeboo@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Shafick Gareeboo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Epsom and St Helier's Hospitals NHS Trust</name>
      <address>
        <city>Carshalton</city>
        <state>Surrey</state>
        <zip>SM5 1AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathon Ratoff</last_name>
      <email>Jonathan.ratoff@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Jonathon Ratoff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Neal Navani</last_name>
      <email>neal.navani@uclh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Neal Navani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Brompton NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anand Deveraj</last_name>
      <phone>020 7352 8121</phone>
      <email>A.Devaraj@rbht.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Dr Anand Deveral</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 12, 2020</study_first_submitted>
  <study_first_submitted_qc>February 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Incidental lung nodules</keyword>
  <keyword>Radiomics</keyword>
  <keyword>Artificial Intelligence</keyword>
  <keyword>Machine Learning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
    <mesh_term>Solitary Pulmonary Nodule</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

